PD-L1 alone versus a five-variable genomic-immunotherapy score for predicting response to immune-checkpoint inhibitors in a real-world multi-tumor cohort: a molecular pathology perspective.
- DOI
- 10.1016/j.ctarc.2026.101450
- Published
- 2026 Sep 25
- Container
- Cancer treatment and research communications
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ctarc.2026.101450,
title = {PD-L1 alone versus a five-variable genomic-immunotherapy score for predicting response to immune-checkpoint inhibitors in a real-world multi-tumor cohort: a molecular pathology perspective.},
author = {Huang X and He D and Shi H and Cui Y and Liang J and Guo J and Shao C and Chen J},
year = {2026},
journal = {Cancer treatment and research communications},
doi = {10.1016/j.ctarc.2026.101450},
url = {https://doi.org/10.1016/j.ctarc.2026.101450}
}RIS
TY - JOUR TI - PD-L1 alone versus a five-variable genomic-immunotherapy score for predicting response to immune-checkpoint inhibitors in a real-world multi-tumor cohort: a molecular pathology perspective. AU - Huang X AU - He D AU - Shi H AU - Cui Y AU - Liang J AU - Guo J AU - Shao C AU - Chen J PY - 2026 JO - Cancer treatment and research communications DO - 10.1016/j.ctarc.2026.101450 UR - https://doi.org/10.1016/j.ctarc.2026.101450 ER -
APA
X, H., D, H., H, S., Y, C., J, L., J, G., C, S., & J, C. (2026). PD-L1 alone versus a five-variable genomic-immunotherapy score for predicting response to immune-checkpoint inhibitors in a real-world multi-tumor cohort: a molecular pathology perspective.. Cancer treatment and research communications. https://doi.org/10.1016/j.ctarc.2026.101450
Source records
- pubmed · retrieved 2026-09-26T10:59:57.914Z